Evidence map

TrialBMJ open2022

Preventing type 2 diabetes, overweight and obesity in the Norwegian primary healthcare: a longitudinal design with 60 months follow-up results and a cross-sectional design with comparison of dropouts versus completers.

Ingrid Sørdal Følling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2022
2023
2024
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35264353